Lymphatic Disease in Cardiology: The Forgettable One
Versions
- 2020-09-19 (2)
- 2020-09-19 (1)
Downloads
Before molecular medicine era, the lymphatic system was not getting enough attention in medicine world, especially in cardiovascular medicine. Our knowledge about lymphatic system is far left behind compare to vascular system. Many believes lymphatic function is isolated in regulate interstitial fluid hemostasis, fat transport, and immune transport. In deep investigation in lymphatic function shows that alteration in lymphatic vessel could disrupt normal cardiovascular function. Moreover, optimal cardiac lymphatic condition after post-heart tissue injury could enhance tissue regeneration. That is why in modern medicine era preserving optimal lymphatic condition and treat abnormal lymphatic condition might be beneficial in cardiovascular medicine.
Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest. 2014;124(3):915-21.
Aspelund A, Robeiue MR, Karman S, Makinen T, Alitalo K. Lymphatic system in cardiovascular medicine. Circ Res. 2006:118:515-30.
Jones D, Min W. An overview of lymphatic vessels and their emerging role in cardiovascular disease. J Cardiovasc Dis Res. 2011;2(3):141-52.
Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular, and functional properties. J Cell Biol. 2003;163(2):209-213.
Kim H, Koh GY. Ang2, the instigator of inflammation. Blood. 2011;118(18);4767-8.
Swartz MA. The physiology of lymphatic system. Adv Drug Deliv Rev. 2001;50:3-20.
Gashev AA. Basic mechanisms controlling lymph transport in the mesenteric lymphatic net. Ann N Y Acad Sci. 2010:1207(1):E16-20.
Huang LH, Lavine KJ, Randolph GJ. Cardiac lymphatic vessels, transport, and healing of the infracted heart. JACC Basic Transl Sci. 2017;2(4):477-83.
Guerin. Reverse cholesterol transport in hdl metabolism: relevance to atherosclerosis progression and cardiovascular diseases. In: Komoda T, editor. The HDL Handbook Biological Functions and Clinical Implications. 3rd ed. Amsterdam:Elsevier;2017.p.97-119.
Sattler S, Fairchild P, Watt FM, Rosenthal N, Harding SE. The adaptive immune response to cardiac injury-the rue roadblock to effective regenerative therapies. NPJ Regen Med. 2017:2(19);1-5.
Lee JJ, Pedley A, Hoffmann U, Massaro JM, Fox CS. Association of changes in abdominal fat and cardiovascular risk factors. J Am Coll Cardiol. 2016;68(14):1509-21.
Despres JP. Cardiovascular disease under the influence of excess visceral fat. Crit Pathw Cardiol. 2007;6(2):51-9.
Despres JP. Body fat distribution and risk of cardiovascular disease. Circulation. 2012:126:1301-13.
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191-200.
Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C. Coronary atherosclerosis is associated with macrophage polarization in peicardial adipose tissue. J Am Coll Cardiol. 2011;58(3):248-55.
Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nav Rev Immunol. 2015;15(2):104-16.
Huang LH, Elvington A, Randolph GJ. The role of the lymphatic system in cholesterol transport. Fron Pharmacol. 2015;6(182):1-11.
Kaya Z, Leib C, Katus HA. Autoantibodies in heart failure and cardiac dysfunction. Circ Res. 2012;110:145-158.
Huang LH, Lavine KJ, Randolph GJ. Cardiac lymphatic vessels, transport, and healing of the infracted heart. Jacc Basic Transl Sci. 2017;2(4):477-83.
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).
